Molecule Details
| InChIKey | YCGPRRDWIJIAAM-UHFFFAOYSA-N |
|---|---|
| Compound Name | 3-[4-(3-Amino-1,2-benzoxazol-4-yl)phenyl]-1-[4-fluoro-3-(trifluoromethyl)phenyl]urea |
| Canonical SMILES | Nc1noc2cccc(-c3ccc(NC(=O)Nc4ccc(F)c(C(F)(F)F)c4)cc3)c12 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 5 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.51 |
| Source | BindingDB;ChEMBL;TTD_MultiTarget |
2D Structure
Activity Profile
Target Activities (5)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P35968 | KDR | Homo sapiens | Human | PF07679 PF00047 PF13895 PF22971 PF07714 PF21339 PF17988 PF22854 | 7.6 | IC50 | ChEMBL;BindingDB |
| Q02161 | RHD | Homo sapiens | Human | PF00909 | 7.6 | pIC50 | TTD_MultiTarget |
| P11511 | CYP19A1 | Homo sapiens | Human | PF00067 | 7.5 | IC50 | BindingDB |
| P36888 | FLT3 | Homo sapiens | Human | PF00047 PF07714 | 7.5 | IC50 | ChEMBL |
| P10721 | KIT | Homo sapiens | Human | PF00047 PF07714 | 7.2 | IC50 | ChEMBL;BindingDB |